← All Congress trades

Biogen Inc. (BIIB) — Congressional Trades

21 U.S. lawmakers have disclosed 72 Biogen Inc. trades under the STOCK Act — 48 buys and 24 sells between 2013 and 2026. Congress has been net buyers of BIIB, and their disclosed buys are up 7.1% versus the latest close.

72Trades
48Buys
24Sells
21Members
$210.65Latest close 2026-08-13
+7.1%Congress buys vs latest close*

*Notional-weighted price return on lawmakers' disclosed buys of BIIB, marked to the latest close — per-share (share counts aren't disclosed).

67% buys33% sells

Lawmakers who bought BIIB recently

1 member disclosed a BIIB purchase in the last 90 days (newest first).

Which party is trading BIIB?

Republicans
30 buys · 12 sells
11 members · 42 trades
Democrats
15 buys · 10 sells
7 members · 25 trades

Who profited most from BIIB?

Lawmakers ranked by notional-weighted return on their disclosed BIIB buys (last ~3y), marked to the latest close.

1 Alan Armstrong
+14.6%
2 Gilbert Cisneros
+7.8%
3 Maria Elvira Salazar
+6.4%
DateMemberTypeAmountEst. priceLatest closeReturn
2026-06-05Gilbert CisnerosBUY$1K–$15K$195.34$210.65 2026-08-13+7.8%
2026-06-02Maria Elvira SalazarSELL$15K–$50K$188.83$210.65 2026-08-13-4.6% rt
2026-05-12Maria Elvira SalazarBUY$1K–$15K$199.36$210.65 2026-08-13+5.7%
2026-05-11Maria Elvira SalazarBUY$50K–$100K$197.95$210.65 2026-08-13+6.4%
2026-05-11Maria Elvira SalazarBUY$1K–$15K$197.95$210.65 2026-08-13+6.4%
2026-03-27Alan ArmstrongBUY$1K–$15K$183.84$210.65 2026-08-13+14.6%
2023-01-23Shri ThanedarSELL$15K–$50K$291.93$210.65 2026-08-13+27.8% exit
2022-01-10Josh GottheimerBUY$1K–$15K$235.31$210.65 2026-08-13-10.5%
2021-12-09Josh GottheimerSELL$1K–$15K$232.43$210.65 2026-08-13-41.2% rt
2021-09-15Josh GottheimerSELL$1K–$15K$299.21$210.65 2026-08-13+11.5% rt
2021-06-08Josh GottheimerBUY$1K–$15K$395.37$210.65 2026-08-13-46.7%
2021-02-02Byron DonaldsBUY$1K–$15K$277.72$210.65 2026-08-13-24.1%
2021-01-04Christopher L. JacobsSELL$1K–$15K$242.95$210.65 2026-08-13+13.3% exit
2020-07-07Josh GottheimerBUY$1K–$15K$268.35$210.65 2026-08-13-21.5%
2019-09-11Dean PhillipsSELL$1K–$15K$235.96$210.65 2026-08-13+0.4% rt
2019-06-20Dean PhillipsBUY$1K–$15K$234.97$210.65 2026-08-13-10.3%
2019-03-22Sheldon WhitehouseSELL$1K–$15K$216.71$210.65 2026-08-13-44.2% rt
2018-10-05Gary PalmerSELL$1K–$15K$342.08$210.65 2026-08-13+38.4% exit
2018-01-08Sheldon WhitehouseSELL$1K–$15K$329.65$210.65 2026-08-13-14.0% rt
2017-06-07James B. RenacciBUY$1K–$15K$255.43$210.65 2026-08-13-17.5%
2017-03-29Lamar SmithSELL$1K–$15K$268.53$210.65 2026-08-13-11.8% rt
2017-01-30Cheri BustosSELL$15K–$50K$276.06$210.65 2026-08-13+23.7% exit
2016-12-23Sheldon WhitehouseSELL$1K–$15K$287.53$210.65 2026-08-13-25.0% rt
2016-12-13Sheldon WhitehouseSELL$15K–$50K$287.38$210.65 2026-08-13-31.3% rt
2016-11-21James B. RenacciBUY$1K–$15K$318.32$210.65 2026-08-13-33.8%
2016-08-11Kurt SchraderBUY$1K–$15K$314.49$210.65 2026-08-13-33.0%
2016-08-03James B. RenacciBUY$1K–$15K$321.34$210.65 2026-08-13-34.5%
2016-08-02James B. RenacciBUY$1K–$15K$330.11$210.65 2026-08-13-36.2%
2016-07-28JOHN BOOZMANSELL$1K–$15K$289.03$210.65 2026-08-13+27.1% exit
2016-07-21James M InhofeSELL$50K–$100K$282.45$210.65 2026-08-13-29.3% rt
2016-07-20James B. RenacciBUY$15K–$50K$262.41$210.65 2026-08-13-19.7%
2016-06-03Ed WhitfieldSELL$1K–$15K$290.23$210.65 2026-08-13+10.7% rt
2016-06-01James B. RenacciBUY$1K–$15K$286.82$210.65 2026-08-13-26.6%
2016-05-31James B. RenacciBUY$1K–$15K$289.73$210.65 2026-08-13-27.3%
2016-05-26James B. RenacciBUY$1K–$15K$282.00$210.65 2026-08-13-25.3%
2016-04-13Ed WhitfieldSELL$1K–$15K$271.73$210.65 2026-08-13+0.7% rt
2016-04-01K. Michael ConawaySELL$1K–$15K$260.54$210.65 2026-08-13-20.6% rt
2016-03-17Tom PriceBUY$1K–$15K$246.31$210.65 2026-08-13-14.5%
2016-02-12James B. RenacciBUY$1K–$15K$247.22$210.65 2026-08-13-14.8%
2016-02-04Ed WhitfieldBUY$1K–$15K$273.27$210.65 2026-08-13-22.9%
2016-01-25Ed WhitfieldBUY$1K–$15K$262.10$210.65 2026-08-13-19.6%
2016-01-19Ed WhitfieldBUY$1K–$15K$269.85$210.65 2026-08-13-21.9%
2016-01-11James B. RenacciBUY$1K–$15K$278.54$210.65 2026-08-13-24.4%
2015-12-09James B. RenacciBUY$15K–$50K$284.61$210.65 2026-08-13-26.0%
2015-09-15James B. RenacciBUY$1K–$15K$319.86$210.65 2026-08-13-34.1%
2015-08-28Sheldon WhitehouseBUY$1K–$15K$303.69$210.65 2026-08-13-30.6%
2015-08-27Lamar SmithBUY$1K–$15K$304.49$210.65 2026-08-13-30.8%
2015-08-26James B. RenacciBUY$1K–$15K$298.25$210.65 2026-08-13-29.4%
2015-08-10Sheldon WhitehouseBUY$1K–$15K$314.94$210.65 2026-08-13-33.1%
2015-08-10Sheldon WhitehouseBUY$1K–$15K$314.94$210.65 2026-08-13-33.1%

Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).

Next →

Frequently asked — Biogen Inc. (BIIB) congressional trades

Which lawmakers have traded Biogen Inc. (BIIB)?

21 members of the U.S. House and Senate have disclosed Biogen Inc. transactions under the STOCK Act — 48 purchases and 24 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought BIIB recently?

1 member disclosed a BIIB purchase in the last 90 days — most recently Gilbert Cisneros on 2026-06-05. See the "Lawmakers who bought BIIB recently" section above for the dated list.

How have Congress's BIIB trades performed?

Notional-weighted, lawmakers' disclosed BIIB buys are up 7.1% versus the latest close of $210.65. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade Biogen Inc.?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded BIIB and how it performed.

Related stocks — also traded by the same lawmakers

MSFT 17AAPL 17AMZN 17UNH 16JPM 13T 13COST 13MA 13GOOG 12FB 12V 12GILD 12IBM 12GOOGL 12PYPL 12DIS 12PFE 12GE 11